Sign inGet started

Bollinger Lisa

Insider CIK 2024557 · APGE Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
APGE Apogee Therapeutics, Inc. D To issuer deriv2026-09-032026-09-038,112— $00SEC↗
APGE Apogee Therapeutics, Inc. D To issuer deriv2026-09-032026-09-0318,550— $00SEC↗
APGE Apogee Therapeutics, Inc. D To issuer deriv2026-09-032026-09-0314,461— $00SEC↗
APGE Apogee Therapeutics, Inc. D To issuer deriv2026-09-032026-09-037,657— $00SEC↗
APGE Apogee Therapeutics, Inc. D To issuer deriv2026-09-032026-09-037,657— —0SEC↗
APGE Apogee Therapeutics, Inc. D To issuer deriv2026-09-032026-09-0314,461— —0SEC↗
APGE Apogee Therapeutics, Inc. D To issuer deriv2026-09-032026-09-038,112— —0SEC↗
APGE Apogee Therapeutics, Inc. D To issuer deriv2026-09-032026-09-0318,550— —0SEC↗
APGE Apogee Therapeutics, Inc. A Award deriv2026-06-092026-06-117,657— $07,657SEC↗
APGE Apogee Therapeutics, Inc. A Award deriv2025-06-172025-06-2014,461— $014,461SEC↗
APGE Apogee Therapeutics, Inc. A Award deriv2024-06-052024-06-078,112— $08,112SEC↗
APGE Apogee Therapeutics, Inc. A Award deriv2024-05-282024-05-3018,550— $018,550SEC↗